Practices:

BGP Litigation provides comprehensive legal support on a wide range of issues in the pharmaceutical and healthcare industries, and supports businesses in projects related to the full cycle of pharmaceutical company activities.

BGP Litigation clients include major national and international pharmaceutical and medical device manufacturers.

The firm's background in the sector includes support for M&A transactions, including counselling on compliance with the antitrust legislation as part of their preparation, dispute resolution, including cross-border disputes, counselling on tax, sanctions, customs law, competition law issues, including compliance with the advertising legislation and development of commercial policies, as well as protecting the interests of clients in relation to intellectual property, taking into account the specifics of the business.

BGP Litigation lawyers help build compliance processes in pharmaceutical companies, develop anti-corruption policies and conduct due diligence. The lawyers’ profound knowledge of this sensitive industry with complex regulation documents allows them to build the risk management system properly, thereby minimising the risk of both fines and reputational damage.

As a multi-disciplinary team of lawyers, BGP Litigation also offers effective solutions on data protection, labour relations, Legal Tech solutions for pharmaceutical companies considering the specifics of the industry.


We advised:

An American Manufacturer of Advanced Medical Equipment and Digital Solutions

in a dispute with the customs authorities regarding refund of overpaid VAT for importing medical equipment into Russia

A Manufacturer of Contact Lenses

on monitoring parallel imports and counterfeit contact lenses within Russia and the EAEU

An International Pharmaceutical Company

on application of investment tax incentives

A Leader in Implantology and Aesthetic Dentistry

on wholesale trade in pharmaceutical products and taxation in Russia, including accounting for costs related to providing goods for promotional purposes, taxation of annual bonuses for former employees working abroad, accounting for costs of catering for doctors during training courses, and tax risks when collaborating with self-employed individuals residing abroad

Antiretroviral Medicine Manufacturer

in analysing the current business structure and business plan for launching new production facilities to maximise use of incentives and minimise tax risks

An International Biopharmaceutical Company

as part of a project to invest in a medical startup – a developer of software for supporting medical decision-making and diagnosing internal organ condition based on X-ray (CT/MRI) images using AI. This included conducting comprehensive legal due diligence on the startup and preparing transactional documentation

A Multinational Pharmaceutical Company

in developing a commercial policy for the Russian market to systematise work with counterparties, including establishing grounds for differentiating commercial terms and categorising counterparties

A Leading Russian Distributor of Anti-Cancer Medicines

in connection with a global biopharmaceutical company’s refusal to renew a supply contract, including liaising with the Federal Antimonopoly Service of Russia (FAS) to ensure the contract was concluded under its oversight

An International Medical Company

on registration of trade marks with the TMOIS, including analysing the prospects for protecting the brand against parallel imports in the EAEU and implementing available protection mechanisms

Team

Irina Akimova
Partner, attorney, member of the General Council of the Association of Antimonopoly Experts — Competition law
Anastasia Dudko
Counsel, attorney — Intellectual Property, Dispute Resolution